Jen Herbach - Y Combinator Founder of Adventris Pharmaceuticals
Home›Founders›Jen Herbach
Jen Herbach, Founder of Adventris Pharmaceuticals

Founder at Adventris Pharmaceuticals

Jen Herbach is the CEO of Adventris Pharmaceuticals. She has more than a decade of biotech industry experience bringing novel oncology drugs to market, across companies including Onyx/Amgen, InterMune/Genentech, Exelixis, and Amunix. She holds an MBA from Harvard Business School and a Masters from the University of Cambridge.

Previously at

Amunix Pharmaceuticals
Amunix Pharmaceuticals
FLX BIO
FLX BIO
Exelixis
Exelixis
Clovis Oncology
Clovis Oncology
InterMune/Genentech
InterMune/Genentech
Onyx Pharma/Amgen
Onyx Pharma/Amgen
Alumnus of
Harvard Business School
Harvard Business School
University of Cambridge
University of Cambridge
Amherst College
Amherst College